SEIZURE FREEDOM IN ADULTS WITH PARTIAL-ONSET SEIZURES TREATED WITH ADJUNCTIVE LACOSAMIDE: POOLED ANALYSIS OF THREE OPEN-LABEL EXTENSION TRIALS

被引：0
|
作者：
Dimova, S. [1 ]
McShea, C. [2 ]
De Backer, M. [1 ]
机构：
[1] UCB Pharma, Brussels, Belgium
[2] UCB Pharma, Raleigh, NC USA
来源：
EPILEPSIA | 2013年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] Lacosamide Efficacy in Partial-Onset Seizures with and without Secondary Generalization: A Pooled Analysis of Three Phase II/III Trials
    Isojarvi, Jouko
    Rosenow, Felix
    Taught, Raymond Edward
    Hebert, David
    Doty, Pamela
    ANNALS OF NEUROLOGY, 2009, 66 : S14 - S15
  • [22] Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
    Zadeh, Wendy Waldman
    Escartin, Antonio
    Byrnes, William
    Tennigkeit, Frank
    Borghs, Simon
    Li, Ting
    Dedeken, Peter
    De Backer, Marc
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 31 : 72 - 79
  • [23] Lacosamide Monotherapy for the Treatment of Partial-Onset Seizures: Post-Hoc Analysis of Responder Rates from a Multicenter, Open-Label Extension Trial
    Vossler, David
    Wechsler, Robert
    Williams, Paulette
    Bymes, William
    Therriault, Sheila
    NEUROLOGY, 2016, 86
  • [24] Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials
    Porter, Roger J.
    Burdette, David E.
    Gil-Nagel, Antonio
    Hall, Susan T.
    White, Robin
    Shaikh, Soraya
    DeRossett, Sarah E.
    EPILEPSY RESEARCH, 2012, 101 (1-2) : 103 - 112
  • [25] LONG-TERM ADJUNCTIVE LACOSAMIDE IN PATIENTS WITH UNCONTROLLED PARTIAL-ONSET SEIZURES: RESULTS FROM THE SP774 PHASE III OPEN-LABEL EXTENSION TRIAL
    Rosenow, F.
    Kelemen, A.
    Ben-Menachem, E.
    McShea, C.
    Isojarvi, J.
    Doty, P.
    EPILEPSIA, 2011, 52 : 156 - 156
  • [26] Intravenous lacosamide as replacement for oral lacosamide in subjects with partial-onset seizures: A multicenter, open-label, inpatient safety and tolerability trial
    Krauss, Gregory
    Ben-Menachem, Elinor
    Mameniskiene, Ruta
    Vaiciene, Nerija
    Whitesides, John
    Brock, Melissa
    NEUROLOGY, 2007, 68 (12) : A125 - A125
  • [27] Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials
    Biton, Victor
    Gil-Nagel, Antonio
    Isojarvi, Jouko
    Doty, Pamela
    Hebert, David
    Fountain, Nathan B.
    EPILEPSY & BEHAVIOR, 2015, 52 : 119 - 127
  • [28] Long-Term Open-Label Study of Adjunctive Topiramate in Infants With Refractory Partial-Onset Seizures
    Puri, Vinay
    Ness, Seth
    Sattaluri, Sita Jayalakshmi
    Wang, Steven
    Todd, Mike
    Yuen, Eric
    Eerdekens, Marielle
    Nye, Jeffrey S.
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Ford, Lisa
    JOURNAL OF CHILD NEUROLOGY, 2011, 26 (10) : 1271 - 1283
  • [29] LONG-TERM SAFETY AND TOLERABILITY OF LACOSAMIDE FOR PARTIAL-ONSET SEIZURES: AN INTERIM EVALUATION OF PATIENTS EXPOSED TO LACOSAMIDE IN DOUBLE-BLIND AND OPEN-LABEL TRIALS
    Rosenfeld, William
    Rosenow, F.
    Isojarvi, J.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 262 - 262
  • [30] Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Patients Exposed to Lacosamide in Double-Blind and Open-Label Trials
    Rosenfeld, William
    Rosenow, Felix
    Isojarvi, Jouko
    Hebert, David
    Doty, Pamela
    NEUROLOGY, 2010, 74 (09) : A452 - A453
12345